HRT Financial’s TherapeuticsMD TXMD Stock Holding History

HRT Financial’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,104	Closed	-$268K	–	3882
2021 Q4	$268K	Sell	15,104 -431	-3%	-$12.9K	﹤0.01%	2340
2021 Q3	$575K	Buy	15,535 +4,313	+38%	+$191K	﹤0.01%	1857
2021 Q2	$667K	Buy	+11,222	New	+$680K	0.01%	1520
2020 Q3	–	Sell	-3,394	Closed	-$212K	–	2365
2020 Q2	$212K	Buy	+3,394	New	+$198K	0.01%	1134
2019 Q3	–	Sell	-1,030	Closed	-$133K	–	1606
2019 Q2	$133K	Buy	1,030 +807	+362%	+$145K	0.01%	657
2019 Q1	$54K	Buy	+223	New	+$59K	0.01%	461

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

HRT Financial's TXMD Position: Q1 2022 in Review

HRT Financial sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 15,104 shares — an estimated $268K sold.

HRT Financial first reported a position in TXMD in Q1 2019 and held it in 6 quarters. The position peaked at $667K in Q2 2021. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

HRT Financial reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
HRT Financial sold 15,104 TherapeuticsMD shares in Q1 2022, an estimated $268K.
HRT Financial first reported a position in TherapeuticsMD in Q1 2019 and held it in 6 quarters.
HRT Financial's TherapeuticsMD position peaked at $667K in Q2 2021.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.